Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that, effective on May 23, 2022 and May 31, 2022, respectively (the “Grant Dates”), the Compensation Committee of Precision’s Board of Directors approved the grant of inducement … [Read more…]

ANP’s Polymeric Drug Excipient Drug Master File (DMF) Accepted and Published by the U.S. Food and Drug Administration (FDA)

NEWARK, Del.–(BUSINESS WIRE)–ANP Technologies, Inc. (ANP) announced that its drug master file (DMF) on its novel, nano-encapsulating polymer-based drug excipient, ANP001B has been accepted and published by the U.S. Food & Drug Administration (FDA). The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform that can be broadly applicable … [Read more…]

Baxter to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

  DEERFIELD, Ill.–(BUSINESS WIRE)–Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 43rd Annual Global Healthcare Conference on Tuesday, June 14, 2022. José (Joe) Almeida, Baxter’s chairman and chief executive officer, is scheduled to present at 10:40 a.m. Pacific Time. The live webcast of Baxter’s presentation can be accessed at … [Read more…]

NANOBIOTIX Annual Shareholders’ General Meeting to Be Held on June 23, 2022

PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Regulatory News: NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that its Annual Combined Shareholders General Meeting will be held on June 23, 2022 at 9.30 AM Central European Time (CET), 3.30 … [Read more…]

Rite Aid to Release First Quarter Results on June 23

CAMP HILL, Pa.–(BUSINESS WIRE)–Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2023 First Quarter, which ended May 28, 2022, on Thursday, June 23, 2022. The company will hold an analyst call at 8:30 a.m. Eastern Time with remarks by Rite Aid’s management team. The call will be … [Read more…]

Volta Labs to Unveil Digital Fluidics at AGBT

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Volta Labs, a bioautomation company developing solutions to streamline the upstream workflows in genomic sequencing, today announced numerous advances in digital fluidics that will be presented at AGBT General Meeting. “We have been hard at work to develop bioautomation technology and we are excited to unveil the company and the technology at AGBT,” … [Read more…]

MeetCaregivers Expanding into Medicare Advantage Business

NEWTON, Mass.–(BUSINESS WIRE)–MeetCaregivers, a health technology company that intelligently matches seniors with the perfect companions, services, care products, and technology tools they need to remain healthy and age independently at home, is aggressively expanding into the Medicare Advantage business. MeetCaregivers aims to solve problems facing seniors, families, and caregivers by promoting access to high-quality care … [Read more…]

Resilience and MD Anderson Launch Joint Venture to Accelerate Development and Manufacturing of Innovative Cell Therapies for Cancer

SAN DIEGO & HOUSTON–(BUSINESS WIRE)–National Resilience, Inc. (Resilience) and The University of Texas MD Anderson Cancer Center today announced the launch of a joint venture, the Cell Therapy Manufacturing Center, to accelerate the development and manufacturing of innovative cell therapies for patients with cancer. Uniting the strengths of Resilience and MD Anderson, the joint venture … [Read more…]

Sarah Cannon to Present Latest Oncology Research Insights at 2022 ASCO® Annual Meeting

NASHVILLE, Tenn.–(BUSINESS WIRE)–#ASCO22–Today, Sarah Cannon Research Institute announced that it will highlight its latest cancer research insights through more than 140 abstracts and presentations at the 2022 American Society of Clinical Oncology (ASCO®) Annual Meeting, taking place in Chicago and online from June 3-7, 2022. Experts from across Sarah Cannon Research Institute’s network will join … [Read more…]

Worldwide Human Growth Hormone Treatment & Drugs Industry to 2032 – by Route of Administration, Application, Distribution Channel and Region –

DUBLIN–(BUSINESS WIRE)–The “Global Human Growth Hormone Treatment & Drugs Market 2022-2032” report has been added to’s offering. A recent market study published on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough research on the … [Read more…]